Efficacy and safety profile of the potent and selective bradykinin B2 receptor antagonist icatibant in healthy volunteers

被引:0
|
作者
Rosenkranz, B.
Brunner-Ferber, F.
Knolle, J.
机构
[1] Jerini AG, Berlin, Germany
[2] Brunner Naga, Hlth Sci Consulting, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:308 / 308
页数:1
相关论文
共 50 条
  • [31] Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist
    Pruneau, D
    Paquet, JL
    Luccarini, JM
    Defrêne, E
    Fouchet, C
    Franck, RM
    Loillier, B
    Robert, C
    Bélichard, P
    Duclos, H
    Cremers, B
    Dodey, P
    IMMUNOPHARMACOLOGY, 1999, 43 (2-3): : 187 - 194
  • [32] The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED
    Bartal, Carmi
    Zeldetz, Vladimir
    Stavi, Vered
    Barski, Leonid
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (03): : 479.e1 - 479.e3
  • [33] INHIBITION OF BRADYKININ-INDUCED VASODILATION IN HUMAN FOREARM VASCULATURE BY ICATIBANT, A POTENT B-2-RECEPTOR ANTAGONIST
    COCKCROFT, JR
    CHOWIENCZYK, PJ
    BRETT, SE
    BENDER, N
    RITTER, JM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (04) : 317 - 321
  • [34] Bradykinin B2 receptor antagonist icatibant reduces inhibitory effect of captopril on growth of cultured neonatal rat cardiomyocytes
    Lei, BL
    Guo, ZG
    ACTA PHARMACOLOGICA SINICA, 1998, 19 (03): : 241 - 244
  • [35] Resolution of symptoms in a patient with Hereditary Angioedema (HAE) following treatment with icatibant, a potent and selective Bradykinin-2 receptor antagonist
    Boehm, T.
    Lumry, W. R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S279 - S279
  • [36] A case series about the treatment of hereditary angioedema due to C1 inhibitor deficiency with icatibant, a selective bradykinin B2 receptor antagonist
    Bork, K.
    ALLERGY, 2010, 65 : 455 - 455
  • [37] NEW HIGHLY POTENT BRADYKININ B2 RECEPTOR ANTAGONISTS
    REGOLI, D
    RHALEB, NE
    TOUSIGNANT, C
    ROUISSI, N
    NANTEL, F
    JUKIC, D
    DRAPEAU, G
    AGENTS AND ACTIONS, 1991, 34 (1-2): : 138 - 141
  • [38] Benzodiazepines as selective bradykinin B2 receptor antagonists
    Leung, C
    Santhakumar, V
    Tomaszewski, M
    Walpole, C
    Woo, S
    Adam, L
    Butterworth, J
    Godbout, C
    Payza, K
    Roumi, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2564 - U2565
  • [39] Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant
    Krause, Karoline
    Metz, Martin
    Zuberbier, Torsten
    Maurer, Marcus
    Magerl, Markus
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (04): : 272 - 274
  • [40] A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor
    Marceau, F
    Fortin, JP
    Morissette, G
    Dziadulewicz, EK
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (10-11) : 1529 - 1536